Objective. To determine the age-and gender-related incidence of chronic renal failure in a French urban area. Methods. Prospective study of adult patients newly identified as having established, chronic renal failure denned by serum creatinine (Scr) ;> 200 umol/1, with the cooperation of all nephrology and dialysis units in the He de France district (10,660,000 inhabitants) during a 1-year period. Results. 2775 patients (1780 males, 995 females) were referred with Scr ^200 umol/1 between July 1991 and June 1992, an overall incidence of 260/million population. 847 had advanced renal failure (Scr ^500 umol/1) and 541 patients (19.5%) were ^75 years of age. The age-related incidence was 92, 264, 523 and 619/million population in the age groups 20-39, 40-59, 60-74 and 75 years old, respectively. The annual incidence was twice as high in males than in females up to 75 years and three times as high in patients ^75 years (1124 vs 356/million population). Based on the proportion of patients reaching end-stage renal failure within one year of referral, the minimal estimation of the need for supportive therapy is 81 /million/year. Conclusions. This epidemiological study in a large French urban area indicates an incidence of 260 patients per million population annually referred to nephrology units for chronic renal failure defined by Scr ^ 200 umol/1, with a marked preponderance of males and a dramatic increase of incidence with age in both genders.
(ESRD) and renal replacement therapy (RRT) by means of maintenance dialysis or renal transplantation becomes necessary. Therefore, proper knowledge of the annual number of new patients reaching ESRD is mandatory in order to define the needs for dialysis hardware. The annual reports of the European Dialysis and Transplant Association-European Renal Association (EDTA-ERA) provide an estimation of the annual incidence of patients requiring RRT in the various European countries. In France, the total number of new ESRD patients accepted for RRT during 1991 was 4350, an incidence of 77.1 patients per million population. This number is based on a 89% response rate by French dialysis units [1] .
However, such studies do not provide information as to the nephrology referral of patients with moderate CRF, susceptible to benefit from therapeutic measures aimed at slowing progression of renal failure [2, 3] . Several prospective studies regarding the incidence of established CRF in the UK [4] [5] [6] [7] have appeared in recent years, but only one such study has been published in France and this was in a rural area [8] .
In order to provide information concerning the incidence of CRF and demographic characteristics of affected patients in a French urban area, a prospective epidemiologic study was undertaken in 1991-1992 with the cooperation of all public and private renal units in the Ile-de-France district, an administrative region comprising the city of Paris and the seven surrounding 'departements', with a total population of 10.66 million inhabitants (National French Census, March, 1990) .
The aim of the study was to identify all patients living in the Ile-de-France district during a 1-year period who had a serum creatinine (Scr) level 5= 200 umol/1 when referred as out-patients, or hospitalized for the first time. Demographic-characteristics, especially gender and age, were analysed in patients stratified with respect to the degree of renal failure.
Subjects and methods
A preliminary pilot study was conducted from January 1 to June 30, 1991. It included all patients with Scr 2=300 umol/1 referred as out-patients or hospitalized in nephrology units of University hospitals in the Paris area. In order to conduct a thorough analysis, the final study was designed over a 1-year period (July 1 1991 until June 30 1992) and extended to all nephrology units, either public or private of the Ilede-France district. The Scr threshold of inclusion was lowered to 200 umol/L, in order to identify patients at the initial stage of renal failure.
In addition, five nephrology units of University hospitals who participated in the preliminary study agreed to provide information on the course of renal disease in their patients 12 months after inclusion in the pilot study. This longitudinal study allowed to determine the proportion of patients with an initial Scr ^ 300 umol/1 who reached ESRD and actually started RRT within 12 months of referral, thus providing basis for an evaluation of the annual incidence of ESRD and need for RRT.
Data were analysed with the Statistica® software package (Statsoft, Tulsa, OK). Data are presented as mean + SD. The Student's t test or the Mann-Whitney test were used to compare means between independent groups. The x 2 test was used to compare percentages. Values of P^0.05 were assumed to be significant.
Results

Overall incidence of CRF
The reply rate was 100% among nephrology departments of University hospitals and 96% among other facilities, an overall response rate of 98%. A total of 2775 charts corresponding to all patients referred to Nephrology units with Scr ^ 200 umol/1 at presentation and living in the Ile-de-France district were recorded during the 1-year study period, an overall incidence of 260/million population. Among them, 1958 (184/million) had a Scr level ^300 umol/1 and 847 (79/million) a Scr level ^500 umol/1.
Demographic characteristics
Distribution of patients with respect to Scr level at presentation for both genders is given in Table 1 . Of the 2775 patients, 1780 (64%) were male and 995 (36%) were female, a sex ratio of 1.79. Almost all were Caucasians (95%). There was no difference between Table 2 . In the whole series, 541 (19.5%) patients (336 males, 205 females) were aged 75 years or more. The mean Scr level and the sex ratio in this group did not differ from the entire series, 414 + 179 umol/1 vs 439+199 umol/1 and 1.64 vs 1.79, respectively. The proportion of patients ^ 75 years of age referred with a Scr level > 500 umol/1 (27%) did not differ from that in the younger patients (31%).
The incidence of patients with Scr ^ 200 umol/1 related to the overall population in each age group is indicated in Table 3 . A continuous increase in incidence is observed with age. The overall incidence of CRF is nearly six times higher in patients aged 60-74 years and nearly seven times higher in those aged ^75 years when compared to the group under 40 years. The increase in the incidence of CRF with age was similar in males and females, but the incidence was twice as high in men than in women in all age groups until 60 years, and three times higher in males in patients over 75 years.
Longitudinal study A sequential evaluation one year after inclusion was performed in a cohort of 251 patients (157 males, 94 females) whose Scr was ^300 umol/1 at presentation. As shown in Table 4 , their gender (sex ratio 1.67) and age distribution (122 patients <60 years, 83 between 60 and 74 years, and 46 ^ 75 years) did not differ from that observed in the whole population, nor did their distribution with respect to Scr range at presentation when compared to the 1958 patients in the whole series whose Scr was ^ 300 umol/1.
The proportion of patients who reached ESRD and started RRT with respect to Scr level at presentation is given in Figure 1 . Overall, 111 (44%) started RRT within 12 months of presentation, whereas 19 (8%) died before reaching ESRD (seven from malignancy, 12 from cardiovascular accidents) and 121 (48%) did not reach ESRD during the observation period. The proportion of patients who actually started dialysis was lower in the group aged ^ 75 years than in younger patients (28% vs 48%, P<0.02), while the proportion of patients who died before reaching ESRD was higher in the older group (18% vs 5%, P<0.0\) ( Table 5 ). Based on the overall proportion of 44.1% of adult patients who reached ESRD within 12 months and assuming that the same proportion would be observed among the total of 1958 patients in the whole series with Scr ^ 300 nmol/1, the incidence of ESRD in the whole series is estimated to be 864 per year, an annual incidence of 81 patients/million population. If corrected for the reply rate (98%), the estimated incidence should be 83/million/year.
Discussion
This prospective, epidemiologic study, involving nearly all nephrology and dialysis centers in the Ile-de-France district, provides the first direct evaluation of the incidence of patients with CRF referred to the nephrologist in a French urban area, together with information on the Scr level at referral and the demographic characteristics of CRF patients. The adopted Scr threshold, 200 umol/1 corresponds to moderate, but established renal failure [9] . At this level, it is desirable that patients are referred to a nephrology specialist. However, the Scr was lower than 300 umol/1 in only 29% of the patients at referral, whereas Scr was greater than 500 umol/1 in 31% of cases. Such late referral to the nephrologist has also been reported in other European countries [4, 7, 10, 11] and in our previous experience [12] , and is especially likely to occur in older patients [4, 7] . A late referral may have adverse consequences in terms of inadequate treatment of hypertension and metabolic disorders of uremia, lack of preparation for dialysis [12, 13] , increased morbidity and mortality after start of RRT [7, 10, 11] and increased expense of therapy [7, 12] .
As suggested by recent studies, earlier referral of hypertensive patients with incipient renal failure could result in more active blood pressure control [14, 15] and early detection and treatment of atheromatous renal artery disease [16, 17] , thus slowing the progression towards ESRD [14, [18] [19] [20] .
We observed an overall incidence of CRF, defined by a Scr value ^200 umol/1 of 260/million/year, which is lower than that reported in several studies in the UK [4] [5] [6] [7] . This could be due to the fact that our study was confined to nephrology units without contribution of other hospital departments or general practitioners. In fact, only 36% of the 304 patients identified as having a Scr level Js 300 umol/1 in the Aberdeen district from July 1989 to June 1990 had been referred to a nephrologist [7] . Interestingly, this corresponds to an incidence of referred patients of 162/million/year, very A salient observation is the strikingly higher incidence of CRF in male than in female patients at every age and in every Scr range. Our results also highlight the considerable increase in the incidence of CRF with age, as the overall annual incidence rose from 64/million in patients under 40 years of age up to 356/million in patients over 75. The increase is most apparent in males, with an incidence peaking at 1124/million in men aged over 75. Such a high incidence of chronic renal failure in elderly patients is probably due to the high prevalence of renal vascular disease in this age group [21, 22] . For example, the age-and gender-adjusted incidence of hypertensionrelated ESRD is 15 times higher in subjects over 60 years than in those aged <30 years [23] . The growing proportion of patients with diabetic nephropathy and hypertensive nephropathy also contributes to the increasing incidence of CRF in older patients [24] .
A growing incidence of ESRD in elderly patients has also been observed in other countries. In Canada, the overall annual incidence of ESRD was 98.4/million population in year 1992, with an incidence of 261/million in people >75 years of age [25] . In the USA, the overall annual incidence of patients accepted for RRT in 1991 was 198/million population, but was more than 600/million in people aged 65-74 years, the most dramatic increase being observed in patients over 75, with a 3.9-fold increase over the past 10 years [24] .
The relentless aging of the population in western countries during the recent decades is in accordance with the progressively increasing age of patients at start of RRT [26, 27] and explains the increasing number of older patients accepted on RRT in all western countries. The combined effects of the increase in the elderly population and the especially high incidence of ESRD in older patients means that there will be an increase in the total number of new patients accepted for RRT in the next years [27] . This is true even if a number of patients-especially those in the older age groups and those with severe comorbid conditions-die before reaching ESRD.
Our estimation of 81 patients/million population in 1991-1992 is in good agreement with the figure in the EDTA-ERA report [1] which states that 77.I/million new patients were accepted on RRT in France in 1991. Similarly, the incidence of ESRD in the London area was estimated at 73/million/year in the 1991-1992 period [6] and at 76/million/year in a rural area in France in the period 1982-1986 [8] .
However, our present study probably underestimates the actual incidence of ESRD in France because the reply rate was slightly lower than 100%, and chiefly because only nephrologists were involved in the study without participation of other hospital physicians or general practitioners. Such limitation in methodology was unavoidable in our study because of the very large number of hospitals (more than 100) and of physicians (more than 30,000) in the Ile-de-France district.
Therefore, it is likely that a number of patients with 1545 advanced renal failure, especially in the oldest age classes, were not referred to nephrology units and were not taken into account in our study. As a matter of fact, among patients identified as having a Scr level > 500 umol/1 in Great Britain, only 54% had been referred to a nephrologist in the study of Feest et al. [4] and 60% in that of Khan et al. [7] . In view of the above-mentioned methodologic limitation, we were not able to assess the proportion of patients with advanced renal failure who were not referred to nephrology units. However, because there is no limitation with respect to age for acceptance of ESRD patients in RRT programs in France, the likely explanation is that family or hospital physicians do not refer patients with severe comorbidity to a nephrologist. As a matter of fact, a substantial proportion of patients in our longitudinal study-especially among those aged ^ 75 years-died before reaching ESRD. Taken together, these considerations indicate that our estimated incidence of ESRD of 81/million/year is a minimal evaluation. In view of the relentless increase in age of populations in industrialized countries and based on a mean increment of 4% per year of new patients reaching ESRD in western Europe [27] , the predictable incidence should reach 100/million population/year by the end of the century.
Because our study was limited to demographic aspects, we cannot provide information as to the types of renal disease responsible for CRF in our patients, nor as to the morbidity and mortality observed after initiation of maintenance dialysis. Other studies aimed at assessing the primary renal disease and comorbidity of patients will be required to properly evaluate the proportion of ESRD patients requiring hospital dialysis, or those who are able to be treated by self-care or home dialysis. Such studies will be of interest to prospectively define the needs for RRT and the structures best adapted to patients' age and comorbid conditions.
Our data emphasize that the referral of patients to the nephrologist is frequently too late. A closer and earlier cooperation between general practitioners, internists and nephrologists should be encouraged in order to provide optimal management of chronic renal failure in the early phase in order to halt, or at least slow the progression towards ESRD, together with preserving the nutritional status and quality of life of patients.
